Dr. Feinstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1267 Highway 54 W
Ste 4200
Fayetteville, GA 30214Phone+1 678-829-1060Fax+1 678-298-3254
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2006 - 2009- UPMC Medical EducationResidency, Internal Medicine, 2003 - 2006
University of Illinois College of MedicineClass of 2003
Certifications & Licensure
GA State Medical License 2011 - 2026
FL State Medical License 2009 - 2013
PA State Medical License 2003 - 2012- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2012
Clinical Trials
- Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer Start of enrollment: 2015 Aug 24
- Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC Start of enrollment: 2015 Dec 01
- Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC Start of enrollment: 2017 Jun 29
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsTrilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer:...Renata Ferrarotto, Ian Anderson, Balazs Medgyasszay, Maria Rosario García-Campelo, William Jeffery Edenfield
Cancer Medicine. 2021-09-01 - 41 citationsSerum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancerAthanassios Argiris, Steve C. Lee, T. M. Feinstein, Sufi M. Thomas, Barton F. Branstetter
Oral Oncology. 2011-10-01 - 33 citationsPrognostic factors in patients with high‐risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapyT. M. Feinstein, Stephen Y. Lai, Diana Lenzner, William E. Gooding, Robert L. Ferris
Head & Neck. 2011-03-01
Press Mentions
BeyondSpring Delivers Oral Presentation at ISLAC 2024 World Conference on Lung Cancer of Its Lead Anti-Cancer Asset Plinabulin Showcasing Positive Final Phase 3 Data in 2L/3L NSCLC EGFR Wild-Type with Concurrent Publication in the Lancet Respiratory MedicineSeptember 10th, 2024- Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLCSeptember 10th, 2024
- BeyondSpring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During ESMO Congress 2024 Showcasing Its Lead Anti-Cancer Asset, PlinabulinSeptember 3rd, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
